FdaApplication
ANDA 078709
Identifiers
- fda_app_no: ANDA078709
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA |
| application_type | ANDA |
| approval_date | 2016-04-01 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ROSIGLITAZONE MALEATE AND GLIMEPIRIDE | GLIMEPIRIDE; ROSIGLITAZONE MALEATE | 1MG;4MG | TABLET;ORAL |
| ROSIGLITAZONE MALEATE AND GLIMEPIRIDE | GLIMEPIRIDE; ROSIGLITAZONE MALEATE | 4MG;4MG | TABLET;ORAL |
| ROSIGLITAZONE MALEATE AND GLIMEPIRIDE | GLIMEPIRIDE; ROSIGLITAZONE MALEATE | 4MG;8MG | TABLET;ORAL |
| ROSIGLITAZONE MALEATE AND GLIMEPIRIDE | GLIMEPIRIDE; ROSIGLITAZONE MALEATE | 2MG;8MG | TABLET;ORAL |
| ROSIGLITAZONE MALEATE AND GLIMEPIRIDE | GLIMEPIRIDE; ROSIGLITAZONE MALEATE | 2MG;4MG | TABLET;ORAL |
5 products